Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
tRNA splicing endonuclease subunit 54 (TSEN54) is a non-catalytic subunit of the tRNA splicing endonuclease complex, an essential cellular enzyme responsible for processing pre-tRNA by removing introns at specific splice sites, which is required for the production of mature, functional tRNA molecules[1][2][3][5][6][7][10]. TSEN54 acts primarily as a structural scaffold and plays a pivotal role in substrate recognition by “measuring” the geometry of pre-tRNA, anchoring it within the multi-subunit complex and ensuring correct cleavage[2][10]. In addition to its central role in tRNA splicing, the complex is implicated in mRNA 3'-end processing and polyadenylation, and possibly other RNA-processing events[1][3][5][6]. Mutations in TSEN54 cause severe neurodevelopmental diseases known as pontocerebellar hypoplasias (PCH), especially types 2A, 4, and 5, which present with profound brain abnormalities, intellectual disability, delayed development, and other neurological deficits[1][7][9]. The pathological mechanism involves failure of tRNA (and potentially mRNA) processing, leading to neurodegeneration and impaired brain growth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on tRNA splicing endonuclease subunit 54 (TSEN54).